|
|
|
|
|
24.06.26 - 21:54
|
Pfizer Declares Third-Quarter 2026 Dividend (Business Wire)
|
|
|
Board of Directors approves quarterly cash dividend of $0.43 per shareNEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 third-quarter 2026 dividend on the company's common stock, payable September 1, 2026, to holders of the Common Stock of record at the close of business on July 24, 2026.
Pfizer is committed to maintaining, and over the longer term, growing the dividend, as part of its capital allocation strategy. The third-quarter 2026 cash dividend will be the 351st consecutive quarterly dividend paid by Pfizer.
About Pfizer: Breakthroughs That Change Patients' Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets...
|
|
|
|
|
|
|
|
|
24.06.26 - 10:42
|
Pfizer Aktie: Pipelineerfolge dringend notwendig (Aktiencheck)
|
|
|
Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG:
Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer aktuellen Aktienanalyse die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol: PFE, NYSE-Symbol: PFE) unter die Lupe. [mehr]...
|
|
|
24.06.26 - 08:15
|
Geheime Chats mit Selenskyj: Ermittlungen gegen von der Leyen (Tichys Einblick)
|
|
|
Der ganze Fall erinnert an das bekannte „Pfizer-Gate“ der Kommissionspräsidentin: In dem Gruppenchat, der geheim bleiben sollte, sprach sich die Kommissionspräsidentin mit hochrangigen Politikern ab, darunter waren der ukrainische Präsident Wolodymyr Selenskyj, Frankreichs Emmanuel Macron, Italiens Giorgia Meloni, der nun zurückgetretene britische Premierminister Keir Starmer und der deutsche Kanzler Friedrich Merz. Das Investigativ-Portal Follow the
Der Beitrag Geheime Chats mit Selenskyj: Ermittlungen gegen von der Leyen erschien zuerst auf Tichys Einblick....
|
|
|
|
|
|
|
|
|
|
|
23.06.26 - 20:01
|
Forget Novo Nordisk. Pfizer’s Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait (24/7 Wall St.)
|
|
|
Everyone is still arguing about Novo Nordisk (NYSE:NVO), the Danish obesity juggernaut whose GLP-1 franchise turned Wegovy and Ozempic into household names and dragged the entire pharma sector into a multi-year hype cycle. But here's what you should actually be watching. The reality check has already started, and the numbers are uglier than the headlines ... Forget Novo Nordisk. Pfizer's Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait...
|
|
|
|
|
|
|
|
|
23.06.26 - 16:03
|
Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EDT on Tuesday, August 4, 2026. The purpose of the call is to provide an update on Pfizer's results, as reflected in the company's Second Quarter 2026 Performance Report, to be issued that morning.
To view and listen to the webcast and view the Performance Report, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance of the conference call.
You can also listen to the conference call by dialing either 800-456-4352 in the United States and Canada or 785-424-1086 outside of the United States and Canada. The passcode is “29301”.
The transcript and webcast replay of the call will be made available on our web site at www.pfizer.com/investors within 24 hours after th...
|
|
|
|
|
23.06.26 - 11:39
|
TRIMTECH Therapeutics Brings Total Seed Round to $47M with Additional Investment of $14M to Further Develop TRIMTAC and TRIMGLUE Targeted Protein Degradation Portfolio (Business Wire)
|
|
|
Johnson & Johnson's corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”), and BGF join existing investors Cambridge Innovation Capital, DDF, M Ventures, Pfizer Ventures, Eli Lilly and Company, MP Healthcare Venture Management (MPH), Cambridge Enterprise VenturesCAMBRIDGE, England--(BUSINESS WIRE)--TRIMTECH Therapeutics (TRIMTECH or the Company), a biotechnology company developing novel small molecule therapies that target and degrade protein aggregates associated with neurodegenerative diseases, today announced it has raised an additional $14 million in seed funding, bringing the total for the round to $47 million (£35 million). The financing was led by Johnson & Johnson's corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. (“JJDC”), and BGF, who join existing investors. This new funding will support the Company as it progresses its proprietary platforms and differentiated portfolio.
Founded on decades of pioneering academi...
|
|
|
23.06.26 - 08:48
|
Pfizer Neutral (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Pfizer auf "Neutral" mit einem Kursziel von 27 US-Dollar belassen. Die Be6A-Lungenkrebsstudie (NSLC) mit Sigvotatug Vedotin habe ihren primären Endpunkt beim Gesamtüberleben verfehlt, schrieb ......
|
|
|
23.06.26 - 08:06
|
Pfizer Buy (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Pfizer von 35 auf 34 US-Dollar gesenkt, aber die Einstufung auf "Buy" belassen. Die Be6A-Lungenkrebsstudie (NSLC) mit Sigvotatug Vedotin habe ihren primären Endpunkt beim Gesamtüberleben ......
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
